Cargando…

Huntington's Disease: Two-Year Observational Follow-Up of Executive Function Evaluation with CNS Vital Signs Test in an Adult Patient

Huntington's disease (HD) is a genetic, degenerative, and progressive central nervous system disease. It is characterized by motor abnormalities and cognitive and psychiatric symptoms. Objective. To describe the precise degree of clinical severity of patients with HD through a new neurocognitiv...

Descripción completa

Detalles Bibliográficos
Autores principales: King, Anna Lucia Spear, Valença, Alexandre Martins, e Silva, Adriana Cardoso de Oliveira, Cerqueira, Ana Claudia, Ferraz, Lígia Maria Chaves, Nardi, Antonio Egidio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235665/
https://www.ncbi.nlm.nih.gov/pubmed/22203851
http://dx.doi.org/10.1155/2011/385894
_version_ 1782218625319436288
author King, Anna Lucia Spear
Valença, Alexandre Martins
e Silva, Adriana Cardoso de Oliveira
Cerqueira, Ana Claudia
Ferraz, Lígia Maria Chaves
Nardi, Antonio Egidio
author_facet King, Anna Lucia Spear
Valença, Alexandre Martins
e Silva, Adriana Cardoso de Oliveira
Cerqueira, Ana Claudia
Ferraz, Lígia Maria Chaves
Nardi, Antonio Egidio
author_sort King, Anna Lucia Spear
collection PubMed
description Huntington's disease (HD) is a genetic, degenerative, and progressive central nervous system disease. It is characterized by motor abnormalities and cognitive and psychiatric symptoms. Objective. To describe the precise degree of clinical severity of patients with HD through a new neurocognitive assessment. Methods. Unprecedented battery of computerized tests, CNSVS (Central Nervous System Vital Signs), was applied at three different moments in 2008, 2009, and 2010. The accurate and reliable CNSVS objectively provided the cognitive state of patients and allowed for the evaluation of disease progression. Case Report. P., 26, female, without any medication, with normal psychomotor development is a parent carrier of HD. In 2008, she was diagnosed with HD in accordance with the Medical Genetics Laboratories. Conclusion. The tests may be useful to reveal the exact measure of the current evolutionary stage of HD patients, allowing for more efficient planning of treatment and future procedures, such as the medication, therapy, and physical activity to be administered.
format Online
Article
Text
id pubmed-3235665
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-32356652011-12-27 Huntington's Disease: Two-Year Observational Follow-Up of Executive Function Evaluation with CNS Vital Signs Test in an Adult Patient King, Anna Lucia Spear Valença, Alexandre Martins e Silva, Adriana Cardoso de Oliveira Cerqueira, Ana Claudia Ferraz, Lígia Maria Chaves Nardi, Antonio Egidio Case Rep Med Case Report Huntington's disease (HD) is a genetic, degenerative, and progressive central nervous system disease. It is characterized by motor abnormalities and cognitive and psychiatric symptoms. Objective. To describe the precise degree of clinical severity of patients with HD through a new neurocognitive assessment. Methods. Unprecedented battery of computerized tests, CNSVS (Central Nervous System Vital Signs), was applied at three different moments in 2008, 2009, and 2010. The accurate and reliable CNSVS objectively provided the cognitive state of patients and allowed for the evaluation of disease progression. Case Report. P., 26, female, without any medication, with normal psychomotor development is a parent carrier of HD. In 2008, she was diagnosed with HD in accordance with the Medical Genetics Laboratories. Conclusion. The tests may be useful to reveal the exact measure of the current evolutionary stage of HD patients, allowing for more efficient planning of treatment and future procedures, such as the medication, therapy, and physical activity to be administered. Hindawi Publishing Corporation 2011 2011-12-04 /pmc/articles/PMC3235665/ /pubmed/22203851 http://dx.doi.org/10.1155/2011/385894 Text en Copyright © 2011 Anna Lucia Spear King et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
King, Anna Lucia Spear
Valença, Alexandre Martins
e Silva, Adriana Cardoso de Oliveira
Cerqueira, Ana Claudia
Ferraz, Lígia Maria Chaves
Nardi, Antonio Egidio
Huntington's Disease: Two-Year Observational Follow-Up of Executive Function Evaluation with CNS Vital Signs Test in an Adult Patient
title Huntington's Disease: Two-Year Observational Follow-Up of Executive Function Evaluation with CNS Vital Signs Test in an Adult Patient
title_full Huntington's Disease: Two-Year Observational Follow-Up of Executive Function Evaluation with CNS Vital Signs Test in an Adult Patient
title_fullStr Huntington's Disease: Two-Year Observational Follow-Up of Executive Function Evaluation with CNS Vital Signs Test in an Adult Patient
title_full_unstemmed Huntington's Disease: Two-Year Observational Follow-Up of Executive Function Evaluation with CNS Vital Signs Test in an Adult Patient
title_short Huntington's Disease: Two-Year Observational Follow-Up of Executive Function Evaluation with CNS Vital Signs Test in an Adult Patient
title_sort huntington's disease: two-year observational follow-up of executive function evaluation with cns vital signs test in an adult patient
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235665/
https://www.ncbi.nlm.nih.gov/pubmed/22203851
http://dx.doi.org/10.1155/2011/385894
work_keys_str_mv AT kingannaluciaspear huntingtonsdiseasetwoyearobservationalfollowupofexecutivefunctionevaluationwithcnsvitalsignstestinanadultpatient
AT valencaalexandremartins huntingtonsdiseasetwoyearobservationalfollowupofexecutivefunctionevaluationwithcnsvitalsignstestinanadultpatient
AT esilvaadrianacardosodeoliveira huntingtonsdiseasetwoyearobservationalfollowupofexecutivefunctionevaluationwithcnsvitalsignstestinanadultpatient
AT cerqueiraanaclaudia huntingtonsdiseasetwoyearobservationalfollowupofexecutivefunctionevaluationwithcnsvitalsignstestinanadultpatient
AT ferrazligiamariachaves huntingtonsdiseasetwoyearobservationalfollowupofexecutivefunctionevaluationwithcnsvitalsignstestinanadultpatient
AT nardiantonioegidio huntingtonsdiseasetwoyearobservationalfollowupofexecutivefunctionevaluationwithcnsvitalsignstestinanadultpatient